Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 8/20 | 0.45 |
| ▸ | LPL | P06858 | 7/20 | 0.45 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.41 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.38 |
| ▸ | KDR | P35968 | 2/20 | 0.38 |
| ▸ | LDHA | P00338 | 1/20 | 0.38 |
| ▸ | ENPP3 | O14638 | 2/20 | 0.36 |
| ▸ | IRAK4 | Q9NWZ3 | 2/20 | 0.35 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.32 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19933638 | 0.96 | LIPG (0.46) | LIPGLPLDGAT1PDGFRBKDR | |
| SCHEMBL20696474 | 0.93 | LIPG (0.43) | LIPGLPLDGAT1PDGFRBKDR | |
| SCHEMBL18015367 | 0.91 | LIPG (0.56) | LIPGLPLDGAT1PDGFRBKDR | |
| SCHEMBL20068707 | 0.91 | LIPG (0.42) | LIPGLPLDGAT1PDGFRBKDR | |
| SCHEMBL19794355 | 0.90 | LIPG (0.43) | LIPGLPLDGAT1PDGFRBKDR | |
| SCHEMBL19833340 | 0.88 | LPL (0.45) | LIPGLPLDGAT1PDGFRBKDR | |
| SCHEMBL18015329 | 0.86 | LIPG (0.57) | LIPGLPLDGAT1PDGFRBKDR | |
| SCHEMBL19933732 | 0.85 | DGAT1 (0.38) | LIPGLPLDGAT1PDGFRBKDR | |
| SCHEMBL19794357 | 0.85 | LIPG (0.46) | LIPGLPLDGAT1PDGFRBKDR | |
| SCHEMBL23018785 | 0.85 | DGAT1 (0.39) | LIPGLPLDGAT1PDGFRBKDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11136343-B2 | Binuclear metal complexes for use as emitters in organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2021-10-05 | — | — | US | disclosed |
| US-20190292210-A1 | BINUCLEAR METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2019-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190292210-A1 | BINUCLEAR METAL COMPLEXES FOR USE AS EMITTERS IN ORGANIC ELECTROLUMINESCENT DEVICES | AP2M1, MCU, AP3M1 | LIPG 3438/4885LPL 3633/4885DGAT1 1147/4885 |
| US-11136343-B2 | Binuclear metal complexes for use as emitters in organic electroluminescent devices | AP2M1, MCU, AP3M1 | LIPG 3438/4885LPL 3633/4885DGAT1 1147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.